Biotechnology News 6 January 2026

Amgen stock jumps on UBS buy call as Dark Blue deal sharpens focus on pipeline

NEW YORK, January 7, 2026, 19:17 EST — After-hours Amgen shares (AMGN.O) rose 3.5% to $341.64 in Wednesday’s regular session and were last near that level after the bell. UBS assumed coverage with a buy rating and a $380 price

8 January 2026

Biotechnology·Financial Analysis·Investments·Pharma News·Stock Market

Thermo Fisher stock slips after-hours as TD Cowen lifts target ahead of JPM talk, earnings

New York, Jan 7, 2026, 18:54 EST — After-hours Thermo Fisher Scientific shares slipped about 0.6% in after-hours trading on Wednesday to $617.15, after swinging between $611.93 and $626.40 during the session. The dip comes with the stock sitting near

8 January 2026

Biotechnology·Earnings Reports·Financial News·Investing·Stock Market

Viasat stock slides as Evergreen signs on for Inmarsat NexusWave, CFO sale hits tape

New York, January 7, 2026, 13:26 EST — Regular session Viasat shares fell $4.89, or about 11.3%, to $38.57 on Wednesday, a day after the stock closed at $43.46. The shares traded between $38.27 and $43.58. The drop comes as

7 January 2026

Biotechnology·Clinical Trials·Pharmaceuticals·Stock Market

Why Wave Life Sciences (WVE) stock is up today after Arrowhead’s obesity data spotlights INHBE

New York, Jan 7, 2026, 12:57 (EST) — Regular session Wave Life Sciences shares rose 4.4% to $15.82 in midday trade on Wednesday. The stock has stayed in motion as investors circle back to obesity plays tied to a gene

7 January 2026

Biotechnology·Investing·Pharma News·Stock Market

Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

New York, January 7, 2026, 12:25 (EST) — Regular session Shares of Adaptive Biotechnologies rose 6.5% to $17.15 on Wednesday, after trading between $16.24 and $17.33, giving the company a market value of about $2.0 billion. The stock has traded

7 January 2026

Biotechnology·Financial News·Insider Trading·SEC Filings·Stock Market

Structure Therapeutics stock climbs on $100 million Roche-Genentech patent deal; what investors watch next

New York, Jan 7, 2026, 11:50 a.m. EST — Regular session Shares of Structure Therapeutics Inc rose 5.6% to $66.75 in late-morning trade on Wednesday, recovering from early swings as investors sized up a newly disclosed patent license deal tied

7 January 2026

Biotechnology·Market News·Stock Analysis

Pfizer stock gains early as UBS starts coverage; Bayer mRNA lawsuit adds fresh risk

New York, January 7, 2026, 09:54 EST — Regular session Pfizer shares rose about 0.9% to $25.67 in morning trade on Wednesday, even as investors weighed a new patent lawsuit tied to its COVID-19 vaccine and a cautious call from

7 January 2026

Biotechnology·Legal Issues·Market Analysis

Regencell Bioscience (RGC) stock jumps again: what to know behind the latest sharp swing

New York, Jan 6, 2026, 12:38 (EST) — Regular session Regencell Bioscience Holdings Ltd shares rose 18.3% to $31.99 on Tuesday, after touching $34.40 earlier and sliding as low as $26.60. The Nasdaq-listed stock was last up $4.95 from Monday’s

6 January 2026

Biotechnology·Financial News·Investing·Market Analysis·Stock Market

Wave Life Sciences stock jumps 17% as obesity gene-silencing race heats up

New York, January 6, 2026, 11:28 EST — Regular session Wave Life Sciences Ltd shares (WVE.O) jumped about 17% on Tuesday, extending sharp swings in the obesity drug trade as investors sized up the next set of clinical readouts. The

6 January 2026

Biotechnology·Pharma Industry·Stock Market

Arrowhead stock leaps after gene-silencing obesity drug doubles Lilly’s Zepbound weight loss

New York, Jan 6, 2026, 11:34 AM EST — Regular session Arrowhead Pharmaceuticals shares rose about 16% on Tuesday after early clinical data showed its experimental gene-silencing obesity drug boosted weight loss when used alongside Eli Lilly’s tirzepatide, sold as

6 January 2026

Biotechnology·Pharmaceuticals

Cyclerion Therapeutics stock jumps in premarket after Medsteer deal — what CYCN investors watch next

NEW YORK, Jan 6, 2026, 08:19 EST — Premarket Cyclerion Therapeutics Inc shares jumped about 46% to around $2.01 in premarket trading on Tuesday after the company announced an expanded strategic collaboration with Medsteer to advance its closed-loop anesthetic platform,

6 January 2026

Biotechnology·Financial Analysis·Investments·Pharma News·Stock Market

GSK stock rises after Japan greenlights twice-yearly Exdensur for severe asthma, nasal polyps

London, January 6, 2026, 09:03 GMT — Regular session GSK plc shares rose nearly 1% in early London trade on Tuesday after the drugmaker said Japan had approved its bronchial asthma treatment Exdensur. Shares were up 0.96% at 1,838 pence

6 January 2026

Biotechnology·Pharma News·Stock Market

Biotechnology News 6 January 2026 - 8 January 2026